Research indicates that resting metabolic rate (RMR) typically decreases during weight loss, partly because a smaller body requires less energy to maintain basic functions
Semaglutide, a GLP-1 receptor agonist approved in 2021, demonstrated much greater weight loss than previous medications, which stimulated the development of poly-agonists that combine GLP-1 receptor agonism with GIP and glucagon receptor agonism
Knee surgery should only be tried as a last resort approach
Ivim Health Supports the Outsourcing Facilities Associations Appeal of Court Ruling That Further Restricts Access to Compounded GLP-1 Medications Recent Federal Court Ruling Denying Request for an Injunction Will Endanger Patients by Limiting Access to Critical Weight Loss & Diabetes Drugs (COLUMBUS, Ohio, March 10, 2025) Ivim Health (Ivim), a leading telehealth platform comprised of obesity medicine physicians and nurse practitioners, joins the Outsourcing Association Facilities (OFA) in publicly disagreeing with a recent federal court ruling that sided with the Biden Administrations FDA
Use whatever youre comfortable with
Importantly, BPC-157s anti-inflammatory mechanisms operate differently from NSAIDs, which have been shown to impair tendon healing when used chronically
